But if we can generate $1B in revenue from selling 100k vials at $10,000 per treatment, what kind of revenue could we generate with 1M vials? $10B in revenue?
We've just seen a total of 700k new cases in two separate days in two different countries. If 10% of the average total become hospitalized and hypoxic, that's 35k patients per day, or 12.7M patients annually.
So, is it unrealistic to think that Humanigen could be looking at stockpile orders totalling 10M vials?
Market Data 
Markets 
AI
